Rondo Therapeutics Appoints Steven James to Board of Directors
Key Highlights Rondo Therapeutics appoints Steven James to its Board of Directors. Mr. James brings over three decades of biopharmaceutical experience. Strengthens Rondo’s…
Browsing Tag
Gilead
3 posts
Andrew Kidd Appointed CEO of Tentarix Biotherapeutics
Key Highlights Andrew Kidd, MD, appointed as CEO of Tentarix Biotherapeutics, previously president and CEO at Aptinyx. Focus on…
NeuroTrauma Sciences Welcomes William Fricker as New CFO
Key Highlights William Fricker, CPA, MBA, appointed as Chief Financial Officer of NeuroTrauma Sciences, bringing over 25 years of…